EMR
65
-8
VFC
76
-3
ROP
38
-10
AMP
73
-3
NKE
43
-6
AMT
37
-2
AN
52
-13
C
79
-2
GE
72
5
FMC
16
-13
CVS
39
-11
VRTX
52
3
SWKS
57
7
CVX
25
-4
WU
54
2
EMN
62
-3
GD
57
-6
EMC
60
-12
CPB
39
2
BK
74
-5
EMR
65
-8
VFC
76
-3
ROP
38
-10
AMP
73
-3
NKE
43
-6
AMT
37
-2
AN
52
-13
C
79
-2
GE
72
5
FMC
16
-13
CVS
39
-11
VRTX
52
3
SWKS
57
7
CVX
25
-4
WU
54
2
EMN
62
-3
GD
57
-6
EMC
60
-12
CPB
39
2
BK
74
-5
Financhill
Back

Ares Dynamic Credit Allocation Fund Vs. Nektar Therapeutics Industry Stock Comparison

Sell
32

ARDC
Ares Dynamic Credit Allocation Fund

Last Price:
$13.36
Seasonality Move:
2.32%
Sell
39

NKTR
Nektar Therapeutics

Last Price:
$53.73
Seasonality Move:
11.58%
Sell
32
Ares Dynamic Credit Allocation Fund (ARDC) is a Sell

Is Ares Dynamic Credit Allocation Fund a Buy, Sell or Hold?

  • The current Ares Dynamic Credit Allocation Fund [ARDC] share price is $13.33. The Score for ARDC is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • ARDC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $54.70. The Score for NKTR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • NKTR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ARDC Stock Price Chart

What is Ares Dynamic Credit Allocation Fund's stock price today?

  • The Ares Dynamic Credit Allocation Fund share price today is $13.33
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ARDC is experiencing slight selling pressure.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $54.70
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing slight buying pressure.

ARDC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.09 Sell
Relative Strength Index (14 RSI): 36.5 Sell
Chaikin Money Flow: -41122 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (13.37 - 13.79) Sell
Bollinger Bands (100): (13.54 - 14.56) Sell

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.71 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 141668 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (54.71 - 61.07) Sell
Bollinger Bands (100): (32.74 - 62.56) Buy

ARDC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 13.41 Sell
20-day SMA: 13.5 Sell
50-day SMA: 13.59 Sell
200-day SMA: 14.03 Sell
8-day EMA: 13.41 Sell
20-day EMA: 13.5 Sell
50-day EMA: 13.68 Sell
200-day EMA: 14.09 Sell

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 56.42 Sell
20-day SMA: 58.12 Sell
50-day SMA: 58.41 Sell
200-day SMA: 30.65 Buy
8-day EMA: 56.16 Sell
20-day EMA: 57.43 Sell
50-day EMA: 55.78 Sell
200-day EMA: 37.86 Buy

Ares Dynamic Credit Allocation Fund Earnings Growth & ARDC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.

Ares Dynamic Credit Allocation Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):